首页|利用金属有机框架抑制PI3K/AKT/mTOR信号传导通路以克服放化疗中的多重耐药性

利用金属有机框架抑制PI3K/AKT/mTOR信号传导通路以克服放化疗中的多重耐药性

扫码查看
原文链接
  • NETL
  • NSTL
  • 万方数据
肿瘤微环境中的血管生成是肿瘤细胞对放化疗不敏感的主要原因.在本项研究中,我们设计了一种微环境响应型的纳米颗粒,利用Zr-MOF的分解产物抑制肿瘤细胞中的PI3K/AKT/mTOR/VEGF通路,从而克服A549R细胞对顺铂的耐药性.我们将顺铂包裹在Zr-MOF中,并在表面修饰BSA,形成了CDDP@Zr-MOF-BSA纳米复合体,该复合体在肿瘤微环境中有良好的响应性,有助于在肿瘤区域蓄积,展现出卓越的血管生成抑制能力,并能明显降低药物的外排.此外,CDDP@Zr-MOF-BSA能显著抑制多药耐药相关蛋白1(MRP1)的表达,从而逆转A549R细胞的耐药性.总体而言,CDDP@Zr-MOF-BSA对A549R有细胞毒性,能抑制肿瘤微环境中的血管生成,最终有效提高顺铂耐药肿瘤的治疗效果.CDDP@Zr-MOF-BSA为放化疗治疗耐药肿瘤提供了一种多功能协同的方法.
Inhibiting PI3K/AKT/mTOR signaling by metal-organic frameworks for overcoming multiple drug resistance in chemoradiotherapy
Angiogenesis in the tumor microenvironment is the main cause for the insensitivity of tumor cells to che-moradiotherapy.Strategies for increasing the sensitivity of tumor cells to conventional therapies using nanoparticles are limited.In this study,we developed rationally designed mi-croenvironment response nanoparticles with physicochemical and biological features to overcome cisplatin resistance by using decomposition product from Zr-metal-organic frame-work(MOF)to inhibit the phosphatidylinositol 3-kinase(PI3K)/AKT/mammalian target of rapamycin(mTOR)/vas-cular endothelial growth factor(VEGF)pathway in chemor-adiotherapy.Cisplatin(CDDP)is encapsulated into Zr-MOF and bovine serum albumin(BSA)is modified into the surface of nanoparticles to create CDDP@Zr-MOF-BSA(abbreviated as CDDP@Zr-MOF),which acts as an excellent radiosensitizer and exhibits microenvironment response,preferable tumor accumulation,high-efficiency inhibition of angiogenesis,and obviously reduced efflux on resistant A549 cells.The rate of angiogenesis inhibition in the combined treatment group is 6-fold higher than that in other control groups.Moreover,CDDP@Zr-MOF not only increases the therapeutic effect re-markably,but also regulates the tumor microenvironment and inhibits the expression of a drug-efflux transporter,namely multidrug resistance-associated protein 1(MRP1),for rever-sing drug resistance in A549R cells.Thus,CDDP@Zr-MOF causes synergistic cytotoxicity in A549R cells,and high-effi-ciency eradication of cisplatin-resistant tumor without re-growth by inhibiting angiogenesis in the tumor microenvironment.The microenvironment responsiveness of CDDP@Zr-MOF provides a multipurpose synergistic ap-proach for treating drug-resistant tumors with chemor-adiotherapy.

angiogenesismultidrug resistanceradiotherapyZr-MOFmicroenvironment

宋春雨、关雪、谢昌明、姜珊、洪智文、吴琼、曲国蕃、马腾闯、崔亚利

展开 >

Department of Orthopedics,Harbin Medical University Cancer Hospital,Harbin 150081,China

Animal Laboratory Center,The Second Affiliated Hospital of Harbin Medical University,Harbin 150081,China

Department of Thyroid Surgery,Key Laboratory of Hepatosplenic Surgery,Ministry of Education,The First Affiliated Hospital of Harbin Medical University,Harbin 150007,China

Department of Nuclear Medicine,Harbin Medical University Cancer Hospital,Harbin 150081,China

Laboratory of Controllable Preparation and Application of Nanomaterials,Key Laboratory of Cryogenics,Technical Institute of Physics and Chemistry,Chinese Academy of Sciences,Beijing 100190,China

展开 >

angiogenesis multidrug resistance radiotherapy Zr-MOF microenvironment

National Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaHarbin Medical University Cancer Hospital Haiyan FoundationHarbin Medical University Cancer Hospital Haiyan FoundationHarbin Medical University Cancer Hospital Haiyan FoundationHeilongjiang Postdoctoral FundHeilongjiang Postdoctoral FundNatural Science Foundation of HeilongjiangNatural Science Foundation of HeilongjiangHeilongjiang Province Youth Innovative Talents Training Program

8217204181801808JJZD202101JJQN2019-02JJZD2018-02LBH-Z18160LBH-TZ2018YQ2023H023LH2020H127UNPYSCT-2020162

2024

10.1007/s40843-023-2774-8

中国科学:材料科学(英文)

中国科学:材料科学(英文)

CSTPCD
ISSN：
年,卷(期)：2024.67(5)